4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta

Clinical Cytology - Oral Presentations
CERVIX CANCER SCREENING IN CROATIA WITHIN THE EUROPEAN CERVICAL
CANCER PREVENTION WEEK
Škopljanac-Mačina L 1 , Mahovlić V 1 , Ovanin-Rakić A 1 , Barišić A 1 , Rajhvajn S 1 , Jurič D 1 ,
Babić D 2 , Ćorušić A 3 , Orešković S 4
1 Department of Gynecologic Cytology, University Department of Gynecology and
Obstetrics, Zagreb University Hospital Center, Zagreb, Croatia
2 Department of Gynecologic and Perinatal Pathology, University Department of Clinical
Pathology, Zagreb University Hospital Center, Zagreb, Croatia
3 Department of Gynecologic Oncology, University Department of Gynecology and
Obstetrics, Zagreb University Hospital Center, Zagreb, Croatia
4 Department of Gynecology and Urogynecology, University Department of Gynecology
and Obstetrics, Zagreb University Hospital Center, Zagreb, Croatia
Aim: To evaluate the outcome of the information campaign “For All Women” and to
provide recommendations for the future national screening programme. Methods: The
European Cervical Cancer Prevention Week was held twice in Croatia, in January 2008
and 2009. Within the first one in 2008, information campaign “For All Women” via mass
media was held, and women were invited to the organized free gynecological examination
and Papanicolaou test (Pap test) in the University Department of Gynecology and
Obstetrics, University Hospital Center Zagreb. Within the European Cervical Cancer
Prevention Week in 2009, employed women from one national company were invited
by internal information to the same procedure. Results: Following invitation during the
campaign “For All Women 2008” 481 women attended the testing; the median age was
55 years. There were more women aged ≥50 (n=353), with the highest participation in
the age group 55-59 years (n=94). Some women came because of subjective symptoms
(n=10), but the majority of them came only for testing (n=471). According to history of previous
cytological testing, 400 women have had ≥1 negative findings, 71 women have had
≥1 positive findings, 9 women attended Pap test for the first time, and 1 woman does not
know about previous testing. Cervical cytology was abnormal in 35 women (7.28%), the
median age was 42 years with the highest proportion in the age group 30-34 years (n=7);
among all of them 21 women (60%) had no abnormal Pap test previously. The findings
were: Atypical squamous cells of undetermined significance - ASC-US (n=9), ASC cannot
exclude high-grade squamous intraepithelial lesion - ASC-H (n=1), cervical intraepithelial
neoplasia - CIN 1 (n=13), CIN 2 (n=1), CIN 3 (n=6), carcinoma planocellulare (n=2), atypical
glandular cells - AGC-favor reactive endocervical cells (n=3). Among women aged £49
there were 20.47% abnormal findings and among those aged ≥50, 2.55%. According to ≥1
positive Pap tests previously, among women aged £49 there were 30.71% while among
those aged ≥50 there were 9.07%. A smaller group of younger asymptomatic women
came for testing in 2009 (n=53), median age 39 years. According to history of previous cytological
testing, 50 women have had ≥1 negative findings, 3 women have had ≥1 positive
findings. In this study, Pap test was positive in 3.77% (n=2). Conclusion: National screening
programme should be focused on the participation of all personally invited women,
especially younger age groups and under-screened women. Well designed information
campaign should be implemented in national screening programme.
lskopljanac@yahoo.com
107
4 th Croatian Congress of Clinical Cytology / 1 st Croatian Symposium of Analytical Cytology / 2 nd Croatian Symposium of Cytotechnology